Logo image
Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets
期刊文章   開放取用(OA)   同儕審查

Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets

Marion Travert, Yenlin Huang, Laurence De Leval, Nadine Martin-Garcia, Marie-Helene Delfau-Larue, Françoise Berger, Jacques Bosq, Josette Brière, Jean Soulier, Elizabeth MacIntyre, …
Blood, 卷.119(24), 頁碼.5795-5806
06/2012
PMID: 22510872

摘要

Biochemistry Immunology Hematology Cell Biology
The pathogenesis of hepatosplenic T-cell lymphoma (HSTL), a rare entity mostly derived from γδ T cells and usually with a fatal outcome, remains largely unknown. In this study, HSTL samples (7γδ and 2αβ) and the DERL2 HSTL cell line were subjected to combined gene-expression profiling and array-based comparative genomic hybridization. Compared with other T-cell lymphomas, HSTL had a distinct molecular signature irrespective of TCR cell lineage. Compared with peripheral T-cell lymphoma, not otherwise specified and normal γδ T cells, HSTL overexpressed genes encoding NK-cell-associated molecules, oncogenes (FOS and VAV3), the sphingosine-1-phosphatase receptor 5 involved in cell trafficking, and the tyrosine kinase SYK, whereas the tumor-suppressor gene AIM1 (absent in melanoma 1) was among the most downexpressed. We found highly methylated CpG islands of AIM1 in DERL2 cells, and decitabine treatment induced a significant increase in AIM1 transcripts. Syk was present in HSTL cells and DERL2 cells contained phosphorylated Syk and were sensitive to a Syk inhibitor in vitro. Genomic profiles confirmed recurrent isochromosome 7q (n = 6/9) without alterations at the SYK and AIM1 loci. Our results identify a distinct molecular signature for HSTL and highlight oncogenic pathways that offer rationale for exploring new therapeutic options such as Syk inhibitors and demethylating agents. © 2012 by The American Society of Hematology.

檔案與連結 (1)

url
https://doi.org/10.1182/blood-2011-12-396150檢視
已出版(紀錄版本) 開放

相關連結

指標

1 檢視次數

詳細資料

Logo image